In addition to developing technologies that overcome some of these limitations, future gene therapy efforts in PTHS should explore approaches to upregulate the intact TCF4 allele, such as CRISPRa approaches, particularly in manners that may be tunable. Here, TCF4 is linked to Pitt-Hopkins syndrome.